Tools that help predict and monitor patient response to opioid medications
The Screener and Opioid Assessment for Patients in Pain (SOAPP) is a validated opioid risk assessment that is completed by a chronic pain patient who is being considered for long term opioid therapy. This assessment is intended to predict which patients may exhibit aberrant medication behaviors in the future. SOAPP is available in an electronic format through PainCAS™.
The Current Opioid Misuse Measure (COMM) will help providers identify whether a patient, currently on long-term opioid therapy, may be exhibiting aberrant behaviors associated with misuse of opioid medications. Since the COMM examines concurrent misuse, it is ideal for helping healthcare providers monitor patients' aberrant medication-related behaviors over the course of treatment. COMM is available in an electronic format through PainCAS .
The SOAPP-R -- containing 24 questions -- was developed to address some of the limitations of the original SOAPP v1.0 by containing more subtle and socially acceptable items that were conceptually and empirically examined. The original SOAPP v1.0 is available as 24 questions (v1.0-24Q), 14 questions (v1.0-14Q), and 5 questions (v1.0-5Q). It was empirically developed and validated with a group of chronic pain patients from pain clinics across the country.
Quick and easy administration and scoring
The SOAPP takes less than 10 minutes to complete and is simple to score. Simply add up the ratings for each of the 14 "screening" questions. The COMM's 17-item questionnaire is easy to understand and takes just minutes to complete and score.
Even patients with a history of substance abuse deserve to have their pain treated. Weaver and Schnoll (2002) note that under-treatment of pain in patients with addiction histories is more likely than adequate treatment to lead to drug-seeking behavior in recovering addicts. Such individuals may require a greater level of monitoring; however, a substance abuse history alone should not deny patients access to opioid therapy. The SOAPP and COMM can help you accurately assess such patients and provide them with appropriate treatment.
What the experts are saying
The Current Opioid Misuse Measure (COMM) has demonstrated promising psychometric properties among pain clinic and primary care patients. Given the high prevalence of the nonmedical use of prescription opioids among substance use disorder patients, the COMM may also be useful in substance use disorder treatment settings."- Evaluation of the Current Opioid Misuse Measure Among Substance Use Disorder Treatment Patients. Ashrafioun, Lisham et al. Journal of Substance Abuse Treatment, Volume 55, 15 - 20